BETTER BODIES, INC. – Trademark Portfolio

Entity Type: 03

BETTER BODIES, INC. holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. The owner is based in NEW YORK, NY.

12 WEST 21ST STREET

NEW YORK, NY 10010

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BETTER BODIES, INC.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

41
Education & Entertainment (5 filings)

Education; providing of training; entertainment; sporting and cultural activities

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (1 filing)

Clothing, footwear, headgear

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does BETTER BODIES, INC. have?

BETTER BODIES, INC. has 10 U.S. trademarks filed with the USPTO.

What trademark classes does BETTER BODIES, INC. file in?

BETTER BODIES, INC. files trademarks across 5 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

What is BETTER BODIES, INC.'s trademark registration success rate?

BETTER BODIES, INC. has a 0% trademark registration rate, with 0 out of 10 resolved applications resulting in successful registration. Currently, 0 applications are pending review.